The HEART Score consists of 5 elements: History, ECG, Age, Risk factors and Troponin. Each element is assigned 0 to 2 points, meaning that a patient can receive a total score ranging from 0 to 10 points. For more information about the original HEART score, see: heartscore.nl
In the ARTICA trials, we use the modified HEAR(T) score, in which troponin is separated from the HEART score. This means that only the first four variables, HEAR, are considered.
Previous research has shown that patients with a modified HEAR(T) score ≤3 and a low troponin level can safely remain at home. The remaining population, patients with a modified HEAR(T) score ≥4, are currently routinely transported to the nearest hospital. We are going to investigate this method of care.
If there is a modified HEAR(T) score of ≥4, we consider the patient to be at intermediate or high risk of acute coronary syndrome (commonly referred to as a heart attack), making them eligible for the ARTICA-2 trial. After inclusion, patients are randomized into two groups.
In the standard care group, the patient will be transported to the Emergency Department (ED) of the nearest hospital, according to current standard care. In the intervention group, point-of-care high-sensitivity troponin (a heart-specific protein) will be measured through a blood sample. This is a rapid test that provides a result within 15 minutes. We use sex-specific cut-off values: values below 13 ng/L for women are considered normal, and values below 28 ng/L for men are considered normal.
The risk of acute coronary syndrome is determined based on the modified HEAR(T) score in combination with the troponin test result. The subsequent management is then adjusted accordingly. With this study, we aim to investigate whether this strategy ensures that patients are taken directly to the most appropriate location for their care.

